Health Services Research
The Division of Health Services Research assesses the organization, financing, and delivery of health care and provides support for investigators working in health services research. Linkages between policy, practice and research highlight the Division of Health Services Research's vision statement:
The Division of Health Services Research conducts nationally recognized research that fosters and supports health policy and improves health care education and practices.
Health services research is "the multidisciplinary field of scientific investigation that studies how social factors, financing systems, organizational structures and processes, health technologies, and personal behaviors affect access to health care, the quality and cost of health care, and ultimately our health and well-being. Its research domains are individuals, families, organizations, institutions, communities, and populations." (p. 8; Lohr & Steinwachs, 2002).
The mission of the Division of Health Services Research is to implement and complete multidisciplinary investigations that examine health care access, quality, cost, and outcomes and emphasize applications to education, policy, and practice.
The Division of Health Services Research serves as a home for health services research within Oregon Health and Science University. We have a core portfolio of research that examines the organization, delivery and financing of services for alcohol, drug and mental health disorders and the outcomes of those services. We collaborate with investigators throughout the university including Emergency Medicine, Family Medicine, Internal Medicine and Psychiatry. A focus on the nexus of policy, practice, and research characterizes much of the work; we conduct community participatory research to assess the impacts of organizational change, facilitate implementation of evidence-based practices, and promote the adoption of evidence-based practices.
Faculty & Research Associates
|Dennis McCarty, PhD||Professor and Head, Division of Health Services||National Drug Abuse Treatment Clinical Trials Network|
|Network for the Improvement of Addiction Treatment|
|Adoption of Buprenorphine|
|Traci Reickman, PhD||Research Assistant Professor||Network for the Improvement of Addiction Treatment|
|Adoption of Evidence Based Practices|
|National Drug Abuse Treatment Clinical Trials Network|
|Community-Based Participatory Research|
|Ana Quiñones, PhD||Assistant Professor||Population aging|
|International Health - comparative aging,health disparities, and immigrant health|
|Lynn Kunkel, MS, CCRP||Senior Research Associate||National Drug Abuse Treatment Clinical Trials Network|
|Kim Hoffman, PhD||Affiliate Instructor
||National Drug Abuse Treatment Clinical Trials Network|
|Network for the Improvement of Addiction Treatment|
|Ariel Singer, MPH||Program and Training Director||Northwest Addiction Technology Transfer Center|
|Don Lollar, EdD
||Associate Director, CDRC Academic Affairs
Director, Oregon Institute on Disability & Development
|Elena Andresen, PhD
||Professor||Aging, disability across the lifespan, health related quality of life methods and measures, and rehabilitation outcomes|
|Barbara Campbell, PhD
|Todd Korthuis, MD, MPH||Internal Medicine|
|John McConnell, PhD||Emergency Medicine|
|Som Saha, MD||Internal Medicine|
The current portfolio of research, education, and service funding reflects interests in benefit design for public health care, purchasing in public benefit programs, quality of care for alcohol and drug disorders and screening and brief interventions for alcohol and drug use disorders.
- National Drug Abuse Treatment Clinical Trials Network. We serve as a regional node for the Clinical Trials Network and work with treatment programs to implement clinical trials that test emerging drug abuse treatments in real world settings. Studies examine emerging pharmacotherapies and behavioral therapies for the treatment of alcohol and drug use disorders. See the NIDA web site for more information (http://www.drugabuse.gov/CTN/Index.htm). Funding from the National Institute on Drug Abuse.
- Network for the Improvement of Addiction Treatment (NIATx). NIATx is a learning community of addiction treatment programs applying process improvement strategies to the organization and delivery of addiction treatment services. Successful programs reduce days to admission and enhance retention in care – www.niatx.net Funding from the National Institute on Drug Abuse.
- Adoption of buprenorphine within an HMO setting. The study explores the impact of buprenorphine on treatment for opiate dependent individuals in two health plans. Administrative data and interviews with patients and staff will be used to assess the cost and utilization of services. Funding from the National Institute on Drug Abuse.
- Adoption of evidence-based practices. Multiple studies examine the implementation and adoption of evidence based practices. We monitor the implementation of legislative requirements to purchase evidence-based practices for substance abuse treatment, survey state addiction treatment authorities, review the implementation of screening and brief intervention, and track patient outcomes in response to process improvements. Funding from the Robert Wood Johnson Foundation through the Substance Abuse Policy Research Program.
Other Recent and Current Awards
- National Institute on Alcohol Abuse and Alcoholism
- Managed Care and the Evolution of Outpatient Services surveyed outpatient alcohol and drug abuse treatment programs in six New England States and assessed changes in the organization and delivery of care over a five year period.
- Implementation of MET/CBT 5 in nine CSAT grantees.
- National Institute on Drug Abuse
- Client and Counselor Attitudes Toward the Use of Medications examines attitudinal and social normative influences on the use of medications to treat heroin dependence. The study provides insights into strategies to facilitate technology transfer and to promote the use of pharmacotherapy for treatment of alcohol and drug disorders.
- Elimination of Methadone Benefits in the Oregon Health Plan: Patient Impacts. This investigation documents the impact of benefits reduction on methadone clients' drug use, legal problems, employment status, use of services, psychiatric health living conditions and other risk behaviors. Findings have public health, economic, and policy impacts.
- Adoption of Buprenorphine in an HMO Setting examines treatment for opioid dependence in a large health plan.
- Northwest Frontier Addiction Technology Transfer Center (NFATTC) began in 1993 as a resource and catalyst for system development within the Northwest and Pacific region's addiction education, treatment and policy-making community. The project serves five states (AK, HI, ID, OR, & WA) and the U.S. affiliated Pacific Island Jurisdictions. The ATTC Network includes 14 independent Regional Centers and a National Office. Each ATTC strives a) to increase the knowledge and skills of addiction treatment practitioners from multiple disciplines by facilitating access to state-of-the-art research and education; b) to heighten the awareness, knowledge, and skills of all professionals who have the opportunity to intervene in the lives of people with substance use disorders; and c) to foster regional and national alliances among practitioners, researchers, policy makers, funders, and consumers that support implementation of best treatment practices. A website (http://www.nfattc.org/NFATTCinfo.htm) provides more details. Funding from the Center For Substance Abuse Treatment.